FEDERATED HERMES, INC.

CIK 0001056288

5 SPACs with a current declared position, filed between Aug 10, 2020 and Jan 10, 2023. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Jan 10, 2023. Read the page below as a record of what was declared, not as a register of what is held.

Filed under 2 earlier names

FEDERATED INVESTORS INC /PA/ · FEDERATED HERMES, INC.EDGAR’s own former-name record for CIK 0001056288. The page did not move when the filer renamed, because the identity is the CIK and the URL is a label it owns.

SPACs declared

every position whose latest statement stands — the record

Re-affirmed in 12 months

filed inside 365 days — what a reader means by "owns"

Still live

positions in SPACs still searching or in an announced deal

Median stake

1.8%

no percentage stated on the cover pages

5 passive (13G)33 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column

5 of 5 shown · 5 positions have not been amended in over a year

	SPAC			Voting	Dispositive			Source
OMEG	Omega Alpha SPAC6 reporting persons on this schedule	7.0%	1,000,000	1,000,000 / 1,000,000	1,000,000 / 1,000,000	Liquidated	Jan 10, 2023Stale	SC 13G/A0001623632-23-000007 3 earlier statements
GDYN	ChaSerg Technology Acquisition Corp5 reporting persons on this schedule	3.9%	2,410,539	2,410,539 / 2,410,539	2,410,539 / 2,410,539	Closed (deSPAC)	Oct 8, 2021Stale	SC 13G/A0001623632-21-001311 5 earlier statements
ARYB	ARYA Sciences Acquisition Corp II5 reporting persons on this schedule	1.8%	2,233,333	2,233,333 / 2,233,333	2,233,333 / 2,333,333	Closed (deSPAC)	Jun 10, 2021Stale	SC 13G/A0001623632-21-000653 10 earlier statements
ARYA	ARYA SCIENCES ACQUISITION CORP.5 reporting persons on this schedule	0.0%	0	0 / 0	0 / 0	Closed (deSPAC)	Aug 10, 2020Stale	SC 13G/A0001623632-20-001420 5 earlier statements
BLSA	BCLS Acquisition Corp.5 reporting persons on this schedule	0.0%	0	0 / 0	0 / 0	Liquidated	Dec 7, 2022Stale	SC 13G/A0001623632-22-001495 10 earlier statements

33 superseded statements (newest 7 shown)

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

BLSA BCLS Acquisition Corp.6.7% · SC 13G/A Feb 14, 2022replaced Dec 7, 2022 by 0001623632-22-001495
OMEG Omega Alpha SPAC7.0% · SC 13G Feb 14, 2022replaced Jan 10, 2023 by 0001623632-23-000007
ARYB ARYA Sciences Acquisition Corp II10.2% · SC 13G/A Apr 9, 2021replaced Jun 10, 2021 by 0001623632-21-000653
BLSA BCLS Acquisition Corp.5.4% · SC 13G Feb 12, 2021replaced Feb 14, 2022 by 0001623632-22-000227
ARYB ARYA Sciences Acquisition Corp II6.3% · SC 13G Feb 12, 2021replaced Apr 9, 2021 by 0001623632-21-000449
GDYN ChaSerg Technology Acquisition Corp5.4% · SC 13G Feb 12, 2021replaced Oct 8, 2021 by 0001623632-21-001311
ARYA ARYA SCIENCES ACQUISITION CORP.5.2% · SC 13G Feb 13, 2020replaced Aug 10, 2020 by 0001623632-20-001420

Reporting persons on this filer's schedules

one filer, several names — collapsed once, shown in full

A joint Schedule 13 names every person who beneficially owns the shares — the management company, the funds it advises, the general partner and often the individual who controls all three. They report the same shares. Counting them separately would publish this filer’s footprint two or three times over, so they are counted once, under CIK 0001056288. This filer has named 6 of them across the schedules in the table above:

(entities only Federated Hermes
Federated Hermes
J. Christopher Donahue
Rhodora J. Donahue
Thomas R. Donahue
Voting Shares Irrevocable Trust

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.